IGC Announces Issuance of Second Patent for the Treatment of Alzheimer's Using THC - IGC Pharma, INC.

Press

Releases

September 21, 2022

IGC Announces Issuance of Second Patent for the Treatment of Alzheimer’s Using THC

Related Posts

IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in its Alzheimer’s Pipeline

November 14, 2024

IGC Pharma Announces Publication of IMS Spotlight Interview Highlighting Strategic Expansion in Alzheimer’s and Weight Loss Therapies

November 6, 2024

IGC Pharma Announces Patient Enrollment at Toronto’s Baycrest in Phase 2 Trial Investigating IGC-AD1

October 17, 2024

CEO Update

Recap of AAIC24 Conference Participation and Poster Presentations

August 28, 2024

Desk of CEO Marijuana Reclass

July 25, 2024